申请人:Eli Lilly and Company
公开号:US04931447A1
公开(公告)日:1990-06-05
This invention provides (8.beta.)-N-cycloalkyl-1-alkyl-6-(substituted) ergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating hypertension, migraine, vasospasm, thrombosis, ischemia, depression, anxiety, sleep disorders and appetite disorders with a compound of the invention.
本发明提供了一种(8.beta.)-N-环烷基-1-烷基-6-(取代基) 艾角酸酰胺,用于阻断中枢或外周存在过量血清素的哺乳动物的5HT.sub.2 受体。本发明还提供了使用本发明化合物治疗高血压、偏头痛、血管痉挛、血栓形成、缺血、抑郁症、焦虑症、睡眠障碍和食欲障碍的方法。